Verastem, Inc. Proceeds from Issuance of Secured Debt
Verastem, Inc. (VSTM) reported Proceeds from Issuance of Secured Debt of $75.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2026-08-06
- Verastem, Inc. proceeds from issuance of secured debt for the quarter ending 2025-12-31 was $0.00.
- Verastem, Inc. proceeds from issuance of secured debt for the quarter ending 2025-09-30 was $0.00.
- Verastem, Inc. proceeds from issuance of secured debt for the quarter ending 2025-06-30 was $0.00.
- Verastem, Inc. proceeds from issuance of secured debt for the quarter ending 2025-03-31 was $75.00M.
- Verastem, Inc. proceeds from issuance of secured debt for fiscal 2025 was $75.00M.
- Verastem, Inc. proceeds from issuance of secured debt for fiscal 2023 was $14.92M, a 38.22% decline from fiscal 2022.
- Verastem, Inc. proceeds from issuance of secured debt for fiscal 2022 was $24.15M, a 2121.53% increase from fiscal 2021.
- Verastem, Inc. proceeds from issuance of secured debt for fiscal 2021 was $1.09M, a 63.58% decline from fiscal 2020.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 6 month | Proceeds from Issuance of Secured Debt 9 month | Proceeds from Issuance of Secured Debt 12 month | Proceeds from Issuance of Secured Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $75.00M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $75.00M 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $75.00M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $75.00M 10-Q · filed 2026-05-07 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $14.92M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $14.92M 10-Q · filed 2024-11-06 | $14.92M derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.92M 10-Q · filed 2024-08-08 | $14.92M derived: sum of 3 quarters · filed 2025-03-20 | $14.92M derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-03-31 | $14.92M 10-Q · filed 2024-05-09 | $14.92M derived: sum of 2 quarters · filed 2025-03-20 | $14.92M derived: sum of 3 quarters · filed 2025-03-20 | $14.29M derived: sum of 4 quarters · filed 2025-03-20 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | -$624.00K derived: sum of 3 quarters · filed 2025-03-20 | $24.15M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$624.00K derived: sum of 2 quarters · filed 2023-11-08 | $24.15M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$624.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $24.15M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | $24.77M 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | $1.09M 10-K · filed 2022-03-28 | ||||
| 2020-12-31 | $2.98M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | -$9.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$9.13M derived: sum of 2 quarters · filed 2022-03-28 | $569.00K 10-K · filed 2022-03-28 | $9.67M 10-K · filed 2020-03-11 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $9.69M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $9.69M 10-Q · filed 2020-08-10 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | $9.90M 10-K · filed 2021-03-18 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $9.90M 10-Q · filed 2019-10-30 | |||
| 2018-06-30 | $9.90M 10-Q · filed 2019-08-01 | ||||
| 2017-12-31 | $14.81M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |